ArticleFrontiers in nutrition2025
Development of a predictive equation for resting energy expenditure in pediatric patients with oncological diagnosis.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and aim: Pediatric cancer is a significant health concern, particularly in low- and middle-income countries with lower cure rates. The nutritional status of these patients is crucial because malnutrition, whether due to a deficiency or excess of energy, can negatively impact treatment response and long-term outcomes. Since resting energy expenditure (REE) is a key parameter for planning appropriate nutritional support, accurate assessment is essential. However, the most precise methods, such as indirect calorimetry (IC), are not always available, leading to predictive equations based on easily accessible variables. These equations may be inaccurate if they are not specifically designed for children with cancer. Therefore, this study presents an equation to estimate REE in pediatric patients with oncological diagnosis and to compare the accuracy of this equation with those of previous equations developed in different pediatric populations to assess its utility in a clinical population. Methodology: A cross-sectional study was conducted in pediatric patients aged 6 to <18 years with a recent oncological diagnosis. After diagnosis, anthropometric measurements were taken, nutritional status was assessed, body composition was determined using bioelectrical impedance, and REE was measured through IC. Results: A total of 226 pediatric participants were evaluated, of whom 203 were included in the final analysis. The majority had solid tumors (68.5%), followed by leukemia (20.2%) and brain tumors (11.3%). Significant differences in anthropometric and biochemical variables were observed among the different diagnoses, with patients with brain tumor having lower REE/kg of body weight. Two new REE prediction equations specific to this population were developed: the INP-simple model, which is based on basic clinical variables, and the INP-Morpho model, which includes body composition. Both new INP equations showed less bias in REE estimation (114.8, 95% CI: -408, 638) than traditional equations, including the Harris-Benedict (-133.6, 95% CI: -671.5, 404.2), FAO (-178.8, 95% CI: -683.9, 326.3), Schofield (-185.4, 95% CI: -697.6, 326.8), IOM (-201, 95% CI: -761.7, 359.7), Oxford (-110.6, 95% CI: -661.4, 440.1), Kaneko (-135.6, 95% CI: -652.5, 381.4) and Müller (-162.6, 95% CI: -715.1, 389.9) equations but not the Molnár equation (-82.3, 95% CI: -741.3, 576.7). Conclusion: Children with cancer often have energy expenditure levels that differ from the recommended values, increasing their risk of malnutrition or obesity. Predictive equations specifically developed for this population may offer improved accuracy for estimating REE in clinical settings, although external validation is still needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.